- Home
- AVIR vs PMTS Comparison
AVIR vs PMTS Comparison
Compare AVIR & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- PMTS
- Stock Information
- Founded
- AVIR 2012
- PMTS 2007
- Country
- AVIR United States
- PMTS United States
- Employees
- AVIR N/A
- PMTS N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- PMTS Finance Companies
- Sector
- AVIR Health Care
- PMTS Finance
- Exchange
- AVIR Nasdaq
- PMTS Nasdaq
- Market Cap
- AVIR 273.7M
- PMTS 327.9M
- IPO Year
- AVIR 2020
- PMTS 2015
- Fundamental
- Price
- AVIR $2.55
- PMTS $23.09
- Analyst Decision
- AVIR Hold
- PMTS Strong Buy
- Analyst Count
- AVIR 1
- PMTS 4
- Target Price
- AVIR $6.00
- PMTS $36.75
- AVG Volume (30 Days)
- AVIR 532.5K
- PMTS 45.7K
- Earning Date
- AVIR 05-12-2025
- PMTS 05-07-2025
- Dividend Yield
- AVIR N/A
- PMTS N/A
- EPS Growth
- AVIR N/A
- PMTS 1.33
- EPS
- AVIR N/A
- PMTS 1.58
- Revenue
- AVIR N/A
- PMTS $491,426,000.00
- Revenue This Year
- AVIR N/A
- PMTS $9.69
- Revenue Next Year
- AVIR N/A
- PMTS $6.30
- P/E Ratio
- AVIR N/A
- PMTS $14.65
- Revenue Growth
- AVIR N/A
- PMTS 12.81
- 52 Week Low
- AVIR $2.60
- PMTS $18.46
- 52 Week High
- AVIR $4.15
- PMTS $35.19
- Technical
- Relative Strength Index (RSI)
- AVIR 37.12
- PMTS 43.32
- Support Level
- AVIR $2.66
- PMTS $19.11
- Resistance Level
- AVIR $3.01
- PMTS $27.00
- Average True Range (ATR)
- AVIR 0.15
- PMTS 1.68
- MACD
- AVIR -0.03
- PMTS -0.22
- Stochastic Oscillator
- AVIR 7.02
- PMTS 52.32
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.